Tissue-Cultured Human Cord Lining Epithelial Cells in Treatment of Persistent Corneal Epithelial Defect

Nguyen Dinh Ngan1,2, Hoang Minh Chau3,4, Pham Ngoc Dong3

  • 1Department of Ophthalmology, 103 Military Hospital, Hanoi, Vietnam.

Insights

Cultivated cord lining epithelial cells (CLECs) show promise for treating persistent corneal epithelial defects (PEDs). This transplantation method is safe and effective, promoting early healing without long-term cell presence.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Persistent corneal epithelial defects (PEDs) are challenging ocular surface disorders.
  • Current treatments for PEDs have limitations.
  • Cultivated amniotic epithelial cell sheets offer a potential new therapeutic approach.

Purpose of the Study:

  • To assess the efficacy of cultivated cord lining epithelial cells (CLECs) sheets for PED treatment.
  • To identify factors influencing the success of CLEC transplantation.

Main Methods:

  • A prospective interventional case series.
  • Transplantation of tissue-cultured human CLECs into 37 eyes with PED.
  • Follow-up included clinical assessment and histopathological analysis.

Main Results:

  • 34 out of 37 eyes healed following CLEC transplantation.
  • 22 eyes healed within one week post-surgery.
  • Histopathology revealed normal corneal scarring without CLEC presence in successful cases.

Conclusions:

  • Tissue-cultured human CLEC transplantation is a safe and effective treatment for PED.
  • CLECs appear to facilitate early epithelial healing.
  • CLECs are not detected long-term at the transplant site.
Abstract